论文部分内容阅读
目的不同手术方式对不同类型剖宫产疤痕妊娠治疗效果分析。方法回顾性分析广东省妇幼保健院2000年1月~2011年10月所收治剖宫产疤痕妊娠68例；其中Ⅰ型剖宫产疤痕妊娠40例行宫腔镜下清宫术（18例未使用垂体后叶素，22例使用垂体后叶素），Ⅱ型剖宫产疤痕妊娠28例行经阴道剖宫产疤痕妊娠切除术（7例未使用垂体后叶素，21例使用垂体后叶素）。结果宫腔镜下清宫术治疗Ⅰ型剖宫产疤痕妊娠：18例（术中未使用垂体后叶素）术中出血量18.89±7.97ml，术后住院天数（2.67±0.59）d，血HCG降至正常天数（24.33±3.74）d；22例（术中使用垂体后叶素）术中出血量（3.45±1.10）ml，术后住院天数2.09±0.53d，血 hCG降至正常天数（23.13±3.92）d。经阴道剖宫产疤痕修补术治疗Ⅱ型剖宫产疤痕妊娠：7例（未使用垂体后叶素）术中出血量（122.86±21.38）ml，术后住院天数3.86±0.69d,血HCG降至正常天数（22.71±3.95）d；21例（使用垂体后叶素），术中出血量（55.24±18.61）ml，术后住院天数（3.67±0.73）d，血HCG降至正常天数24.29±4.15d。二种方法采用垂体后叶素组较不采用垂体后叶素组术中出血量明显减少，有统计学差异（P<0.05）。结论采用宫腔镜下清宫术+垂体后叶素治疗Ⅰ型 CSP效果好，术后并发症少。治疗Ⅱ型CSP最佳治疗方式是经阴道剖宫产疤痕切除术+垂体后叶素。“,”Objective Compare the therapy ef ects of dif erent operations on cesarean scar pregnancy (CSP). Methods: A retrospective analysis method was applied to analysis 68 CSP cases admit ed by Guangdong Women and Children Hospital from Jan 2000 to Oct 2011. 40 cases of them accepted the uterine hysteroscopy curet age:18 cases not used Pituitrin,22 cases used Pituitrin. The left 28 cases with transvaginal operation:7 cases not used Pituitrin,21cases used Pituitrin. Results: Therapy for CSPⅠwith uterine hysteroscopy curet age operation: The average amount of intraoperative blood loss in 18 cases (not used pituitrin) was 18.89 ±7.97ml, the average postoperative hospitalization was 2.09±0.53d, the time of blood hCG level back to norma1 was 24.33±3.74d. The average amount of the other group (used Pituitrin) was 3.45 ±1.10ml, the average postoperative hospitalization was 2.67 ±0.59d, the time of blood hCG level back to norma1 was 23.13 ±3.92d. The dif erence of the average amount of intraoperative blood loss was statistical y significant between the two groups in CSP Ⅰ (P<0.05). Therapy for CSPⅡby vaginal repair: the average amount of intraoperative blood loss in 7 cases(not used pituitrin) was 122.86±21.38ml, in 21 cases ( used pituitrin) was 55.24±18.61ml; and the average postoperative hospitalization of the former was 3.86±0.69d, the lat er was 3.67±0.73d; the time of blood hCG level back to norma1 of the former was 22.71±3.95d , the lat er was 24.29±4.15d. The dif erence of the average amount of intraoperative blood loss was statistical y significant between the two groups in CSP Ⅱ (P<0.05). Conclusion: The therapy by transvaginal partial lesion resection combined with pituitrin has significant advantages in operation safety in the surgical treatment of CSPⅡ. The treatment of CSPⅠby uterine hysteroscopy curet age combined pituitrin has more outstanding advantages on treatment ef ect, such as intraoperative blood loss.